259 related articles for article (PubMed ID: 26097538)
21. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
22. CD147 expression in pituitary adenomas and its significance for clinical outcome.
Qu X; Yang W; Jiang M; Han T; Han L; Qu Y; Wang G; Shi D; Xu G
Hum Pathol; 2010 Aug; 41(8):1165-71. PubMed ID: 20381119
[TBL] [Abstract][Full Text] [Related]
23. High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells.
Páez Pereda M; Ledda MF; Goldberg V; Chervín A; Carrizo G; Molina H; Müller A; Renner U; Podhajcer O; Arzt E; Stalla GK
J Clin Endocrinol Metab; 2000 Jan; 85(1):263-9. PubMed ID: 10634397
[TBL] [Abstract][Full Text] [Related]
24. PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age.
Trott G; Ongaratti BR; de Oliveira Silva CB; Abech GD; Haag T; Rech CGSL; Ferreira NP; da Costa Oliveira M; Pereira-Lima JFS
Ann Diagn Pathol; 2019 Aug; 41():83-89. PubMed ID: 31154064
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers of aggressive pituitary adenomas.
Mete O; Ezzat S; Asa SL
J Mol Endocrinol; 2012 Oct; 49(2):R69-78. PubMed ID: 22822048
[TBL] [Abstract][Full Text] [Related]
27. The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs.
Liu LP; Liang HF; Chen XP; Zhang WG; Yang SL; Xu T; Ren L
Cancer Invest; 2010 Jun; 28(5):443-51. PubMed ID: 20073580
[TBL] [Abstract][Full Text] [Related]
28. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas.
Jin Kim Y; Hyun Kim C; Hwan Cheong J; Min Kim J
Tumori; 2011; 97(5):639-46. PubMed ID: 22158497
[TBL] [Abstract][Full Text] [Related]
29. Functional role of estrogen in pituitary tumor pathogenesis.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2002 Jan; 109(2):277-83. PubMed ID: 11805140
[TBL] [Abstract][Full Text] [Related]
30. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
31. Relationship between expression of vascular endothelial growth factor and the proliferation of prolactinomas.
Li N; Jiang Z
Clin Neurol Neurosurg; 2017 Feb; 153():102-106. PubMed ID: 28110235
[TBL] [Abstract][Full Text] [Related]
32. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
Zhang Y; He N; Zhou J; Chen Y
Clin Imaging; 2011; 35(3):165-73. PubMed ID: 21513851
[TBL] [Abstract][Full Text] [Related]
33. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
34. Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.
Li S; Zhang Z; Xue J; Guo X; Liang S; Liu A
Med Sci Monit; 2015 Aug; 21():2433-8. PubMed ID: 26286316
[TBL] [Abstract][Full Text] [Related]
35. [Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].
Wang J; Liu YS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):647-50. PubMed ID: 16114548
[TBL] [Abstract][Full Text] [Related]
36. MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo.
Ulasov I; Borovjagin AV; Kaverina N; Schroeder B; Shah N; Lin B; Baryshnikov A; Cobbs C
Cancer Lett; 2015 Sep; 365(2):240-50. PubMed ID: 26052095
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
38. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
Gu YH; Feng YG
J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
